Erik Glocker

2.1k total citations · 1 hit paper
21 papers, 1.5k citations indexed

About

Erik Glocker is a scholar working on Surgery, Immunology and Small Animals. According to data from OpenAlex, Erik Glocker has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Immunology and 7 papers in Small Animals. Recurrent topics in Erik Glocker's work include Helicobacter pylori-related gastroenterology studies (13 papers), Veterinary medicine and infectious diseases (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Erik Glocker is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (13 papers), Veterinary medicine and infectious diseases (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Erik Glocker collaborates with scholars based in Germany, United Kingdom and United States. Erik Glocker's co-authors include Bodo Grimbacher, Manfred Kist, Alejandro A. Schäffer, Klaus Warnatz, Hermann Eibel, Beate Fischer, Hans Peter, Richard A. Kroczek, Michael Schlesier and Hans Werner Mages and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Erik Glocker

21 papers receiving 1.4k citations

Hit Papers

Homozygous loss of ICOS is associated with adult-onset co... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Glocker Germany 15 932 519 346 250 237 21 1.5k
Matthias Eck Germany 21 683 0.7× 483 0.9× 113 0.3× 116 0.5× 153 0.6× 45 1.6k
Samuel Lundin Sweden 22 916 1.0× 416 0.8× 182 0.5× 53 0.2× 134 0.6× 41 1.7k
Jennifer M. Noto United States 25 505 0.5× 979 1.9× 115 0.3× 119 0.5× 286 1.2× 42 1.6k
Dominique Velin Switzerland 20 734 0.8× 485 0.9× 109 0.3× 77 0.3× 130 0.5× 50 1.3k
Bernd Schmaußer Germany 16 751 0.8× 607 1.2× 40 0.1× 148 0.6× 187 0.8× 30 1.5k
Kathryn Lynch–Devaney United States 9 522 0.6× 714 1.4× 218 0.6× 33 0.1× 131 0.6× 9 1.5k
Hiroyuki Suto Japan 18 763 0.8× 1.4k 2.7× 39 0.1× 315 1.3× 293 1.2× 47 1.6k
J I Wyatt United Kingdom 19 1.2k 1.3× 2.8k 5.3× 78 0.2× 570 2.3× 613 2.6× 26 3.1k
Liviu A. Sicinschi United States 15 421 0.5× 770 1.5× 54 0.2× 105 0.4× 224 0.9× 22 1.0k

Countries citing papers authored by Erik Glocker

Since Specialization
Citations

This map shows the geographic impact of Erik Glocker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Glocker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Glocker more than expected).

Fields of papers citing papers by Erik Glocker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Glocker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Glocker. The network helps show where Erik Glocker may publish in the future.

Co-authorship network of co-authors of Erik Glocker

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Glocker. A scholar is included among the top collaborators of Erik Glocker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Glocker. Erik Glocker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldmann, Britta, Jürg Meyer, Stephan Miehlke, et al.. (2019). Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018. Clinical Microbiology and Infection. 26(2). 235–239. 26 indexed citations
2.
Miehlke, Stephan, Thomas Günther Pomorski, Erik Glocker, et al.. (2017). Efficacy of three‐in‐one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population. Helicobacter. 22(6). 12 indexed citations
3.
Scherübl, Hans, Wolfgang Fischbach, Erik Glocker, & Peter Malfertheiner. (2015). Was ist neu bei der Behandlung der Helicobacter-pylori-Infektion?. DMW - Deutsche Medizinische Wochenschrift. 140(4). 277–280. 3 indexed citations
4.
Bauer, Georg, Stefan Bereswill, Peter Aichele, & Erik Glocker. (2014). Helicobacter pylori protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosis. Carcinogenesis. 35(7). 1582–1591. 26 indexed citations
5.
Glocker, Erik & Bodo Grimbacher. (2011). Inflammatory bowel disease: is it a primary immunodeficiency?. Cellular and Molecular Life Sciences. 69(1). 41–48. 68 indexed citations
6.
Glocker, Erik & Bodo Grimbacher. (2010). Chronic mucocutaneous candidiasis and congenital susceptibility to Candida. Current Opinion in Allergy and Clinical Immunology. 10(6). 542–550. 41 indexed citations
7.
Ménard, Sandrine, Michael Lotz, Dominique Gütle, et al.. (2008). Developmental switch of intestinal antimicrobial peptide expression. The Journal of Experimental Medicine. 205(1). 183–193. 113 indexed citations
8.
Glocker, Erik, Stephan Ehl, & Bodo Grimbacher. (2007). Common variable immunodeficiency in children. Current Opinion in Pediatrics. 19(6). 685–692. 28 indexed citations
9.
Glocker, Erik, Christian Bogdan, & Manfred Kist. (2007). Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. Journal of Antimicrobial Chemotherapy. 59(5). 874–879. 52 indexed citations
10.
Bohn, Georg, Gudrun Brandes, Jens Thiel, et al.. (2006). A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nature Medicine. 13(1). 38–45. 136 indexed citations
11.
Glocker, Erik, et al.. (2006). Quinolone Resistance in Helicobacter pylori Isolates in Germany. Antimicrobial Agents and Chemotherapy. 51(1). 346–349. 75 indexed citations
12.
Kist, Manfred, Erik Glocker, & Sebastian Suerbaum. (2005). Pathogenese, Diagnostik und Therapie der Helicobacter-pylori-Infektion. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 48(6). 669–678. 2 indexed citations
13.
Glocker, Erik, et al.. (2005). Real-Time PCR Screening for 16S rRNA Mutations Associated with Resistance to Tetracycline in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 49(8). 3166–3170. 39 indexed citations
14.
Bohn, Georg, Jens Thiel, Alejandro A. Schäffer, et al.. (2005). A Variant of Congenital Neutropenia Is Caused by a 3′-UTR Mutation in the Gene Encoding the Endosomal Adaptor Protein p14 (MAPBPIP).. Blood. 106(11). 92–92. 6 indexed citations
15.
Kist, Manfred & Erik Glocker. (2004). ResiNet – a nationwide German sentinel study for surveillance and analysis of antimicrobial resistance in Helicobacter pylori. Weekly releases (1997–2007). 8(9). 11 indexed citations
17.
Braig, David, A.A. Schäffer, Erik Glocker, et al.. (2003). Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity. Human Genetics. 112(4). 369–378. 16 indexed citations
18.
Grimbacher, Bodo, Andreas Hutloff, Michael Schlesier, et al.. (2003). Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nature Immunology. 4(3). 261–268. 534 indexed citations breakdown →
19.
Glocker, Erik, et al.. (1998). Proteins Encoded by thecagPathogenicity Island ofHelicobacter pyloriAre Required for NF-κB Activation. Infection and Immunity. 66(5). 2346–2348. 135 indexed citations
20.
Lange, C., Erik Glocker, Antonello Covacci, et al.. (1997). A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. The Journal of Immunology. 159(12). 6140–6147. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026